UK Insulin Delivery Devices Market Size & Outlook, 2024-2030
Related Markets
UK insulin delivery devices market highlights
- The UK insulin delivery devices market generated a revenue of USD 720.1 million in 2023 and is expected to reach USD 1,326.7 million by 2030.
- The UK market is expected to grow at a CAGR of 9.1% from 2024 to 2030.
- In terms of segment, insulin pens was the largest revenue generating product in 2023.
- Insulin Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
Insulin delivery devices market data book summary
| Market revenue in 2023 | USD 720.1 million |
| Market revenue in 2030 | USD 1,326.7 million |
| Growth rate | 9.1% (CAGR from 2024 to 2030) |
| Largest segment | Insulin pens |
| Fastest growing segment | Insulin Pumps |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin Pens, Insulin Pumps, Insulin Pen Needles, Insulin Syringes |
| Key market players worldwide | Novo Nordisk A/S ADR, Sanofi SA, Eli Lilly and Co, Ypsomed Holding AG, Medtronic PLC, Abbott Laboratories, Roche, Biocon, Wockhardt |
Other key industry trends
- In terms of revenue, UK accounted for 4.4% of the global insulin delivery devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany insulin delivery devices market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,326.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Delivery Devices Market Scope
Insulin Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Wockhardt | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://wockhardt.com |
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
UK insulin delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin delivery devices market will help companies and investors design strategic landscapes.
Insulin pens was the largest segment with a revenue share of 47.91% in 2023. Horizon Databook has segmented the UK insulin delivery devices market based on insulin pens, insulin pumps, insulin pen needles, insulin syringes covering the revenue growth of each sub-segment from 2018 to 2030.
According to the National Health Service (NHS), as of December 2022, over 200,000 patients with type 1 diabetes have been using insulin delivery devices, which enable them to check their glucose levels conveniently and frequently.
The NHS has made these devices available to patients with type 1 diabetes at a similar cost to flash monitors, and almost two-thirds of local NHS areas are currently providing this technology to patients. This has been a life-changing development for around eight in ten people with type 1 diabetes who now have access to this technology.
Moreover, the UK has several small- and medium-sized companies that significantly contribute to the economy. The turnover from these companies is valued at about 99.5% of all businesses currently operating in the UK.
Reasons to subscribe to UK insulin delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK insulin delivery devices market databook
-
Our clientele includes a mix of insulin delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK insulin delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into UK insulin delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK insulin delivery devices market size, by product, 2018-2030 (US$M)
UK Insulin Delivery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
